Presence of macroalbuminuria predicts severe hypoglycemia in patients with type 2 diabetes: A 10-year follow-up study

Diabetes Care

Volumn 36, Issue 5, 2013, Pages 1283-1289

  Yun, Jae Seung ^a   Ko, Sun Hye ^a   Ko, Sun Hee ^a   Song, Ki Ho ^a   Ahn, Yu Bae ^a   Yoon, Kun Ho ^a   Park, Yong Moon ^a   Ko, Seung Hyun ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGE; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIABETIC NEPHROPATHY; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EMERGENCY CARE; ESTIMATED GLOMERULUS FILTRATION RATE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPOGLYCEMIA; INCIDENCE; LENGTH OF STAY; LONGITUDINAL STUDY; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY;

ADULT; AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 84876793169     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1408     Document Type: Article

References (40)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-853
2. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-412 (Pubitemid 30609442)
3. Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 2001;322:15-18 (Pubitemid 32066250)
4. Gerstein HC, Miller ME, Byington RP, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559 (Pubitemid 351831356)
5. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572 (Pubitemid 351831357)
6. Abraira C, Duckworth W, McCarren M, et al; VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial. J Diabetes Complications 2003;17:314-322 (Pubitemid 37315940)
7. Cryer PE. Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 1994;43:1378-1389
8. Akram K, Pedersen-Bjergaard U, Borch-Johnsen K, Thorsteinsson B. Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: A literature survey. J Diabetes Complications 2006; 20:402-408 (Pubitemid 44740218)
9. Ginde AA, Espinola JA, Camargo CA Jr. Trends and disparities in U.S. emergency department visits for hypoglycemia, 1993-2005. Diabetes Care 2008;31:511-513
10. Johnson ES, Koepsell TD, Reiber G, Stergachis A, Platt R. Increasing incidence of serious hypoglycemia in insulin users. J Clin Epidemiol 2002;55:253-259 (Pubitemid 34195521)
11. Donnelly LA, Morris AD, Frier BM, et al.; DARTS/MEMO Collaboration. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: A population-based study. Diabet Med 2005;22:749-755 (Pubitemid 40805897)
12. Moen MF, Zhan M, Hsu VD, et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 2009;4:1121-1127
13. Wang J, Geiss LS, Cheng YJ, et al. Longterm and recent progress in blood pressure levels among U.S. adults with diagnosed diabetes, 1988-2008. Diabetes Care 2011; 34:1579-1581
14. Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 28: 1245-1249
15. Holstein A, Plaschke A, Egberts E-H. Clinical characterisation of severe hypo-glycaemia-a prospective population-based study. Exp Clin Endocrinol Diabetes 2003; 111:364-369 (Pubitemid 37254614)
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999;130:461-470 (Pubitemid 29135798)
17. American Diabetes Association and the National Kidney Foundation. Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. Diabetes Care 1994;17:1357-1361
18. Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002; 346:1145-1151 (Pubitemid 34984606)
19. Ruggenenti P, Remuzzi G. Nephropathy of type-2 diabetes mellitus. J Am Soc Nephrol 1998;9:2157-2169 (Pubitemid 28482168)
20. Ruggenenti P, Remuzzi G. The diagnosis of renal involvement in non-insulin-dependent diabetes mellitus. Curr Opin Nephrol Hypertens 1997;6:141-145 (Pubitemid 27211775)
21. The Diabetes Control and Complications Trial Research Group. Hypogly-cemia in the Diabetes Control and Complications Trial. Diabetes 1997;46: 271-286
22. Leese GP, Wang J, Broomhall J, et al.; DARTS/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: A population-based study of health service resource use. Diabetes Care 2003; 26:1176-1180 (Pubitemid 36929268)
23. Pedersen-Bjergaard U, Pramming S, Heller SR, et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004;20:479-486 (Pubitemid 40028649)
24. ter Braak EW, Appelman AM, van de Laak M, Stolk RP, van Haeften TW, Erkelens DW. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 2000; 23: 1467-1471
25. Abraira C, Colwell JA, Nuttall FQ, et al.; Veterans Affairs Cooperative Study in Type II Diabetes. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Diabetes Care 1995;18:1113-1123
26. Murata GH, Duckworth WC, Shah JH, Wendel CS, Mohler MJ, Hoffman RM. Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: A prospective study of 1662 episodes. J Diabetes Complications 2005;19:10-17 (Pubitemid 40092365)
27. Seaquist ER, Miller ME, Bonds DE, et al.; ACCORD Investigators. The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study. Diabetes Care 2012;35:409-414
28. Holstein A, Patzer OM, Machalke K, Holstein JD, Stumvoll M, Kovacs P. Substantial increase in incidence of severe hypoglycemia between 1997-2000 and 2007-2010: A German longitudinal population-based study. Diabetes Care 2012;35:972-975
29. Kim JT, Oh TJ, Lee YA, et al. Increasing trend in the number of severe hypoglycemia patients in Korea. Diabetes Metab J 2011;35: 166-172
30. Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med 2003;20:1016-1021 (Pubitemid 41701483)
31. Meyer C, Dostou JM, Gerich JE. Role of the human kidney in glucose counter-regulation. Diabetes 1999;48:943-948 (Pubitemid 29226338)
32. Snyder RW, Berns JS. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.SeminDial 2004;17:365-370 (Pubitemid 39422090)
33. Biesenbach G, Raml A, Schmekal B, Eichbauer-Sturm G. Decreased insulin requirement in relation to GFR in neph-ropathic Type 1 and insulin-treated Type 2 diabetic patients. Diabet Med 2003;20: 642-645 (Pubitemid 36966558)
34. Gerich JE, Meyer C, Woerle HJ, Stumvoll M. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 2001;24:382-391 (Pubitemid 32119142)
35. Weir MA, Gomes T, Mamdani M, et al. Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: A population-based nested case-control study. Nephrol Dial Transplant 2011;26:1888-1894
36. Patrick AW, Hepburn DA, Craig KJ, Thomson I, Swainson CP, Frier BM. The effects of acute insulin-induced hypo-glycaemia on renal function in normal human subjects. Diabet Med 1989;6:703-708 (Pubitemid 19265969)
37. Patrick AW, Hepburn DA, Swainson CP, Frier BM. Changes in renal function during acute insulin-induced hypoglycaemia in patients with type 1 diabetes. Diabet Med 1992;9:150-155
38. Takahashi N, Anan F, Nakagawa M, et al. Microalbuminuria, cardiovascular auto-nomic dysfunction, and insulin resistance in patients with type 2 diabetes mellitus. Metabolism 2004;53:1359-1364 (Pubitemid 39222100)
39. Torffvit O, Lindqvist A, Agardh CD, Pahlm O. The association between diabetic ne-phropathy and autonomic nerve function in type 1 diabetic patients. Scand J Clin Lab Invest 1997;57:183-191
40. Meyer C, Grossmann R, Mitrakou A, et al. Effects of autonomic neuropathy on coun-terregulation and awareness of hypoglyce-mia in type 1 diabetic patients. Diabetes Care 1998;21:1960-1966 (Pubitemid 28478301)